NASDAQ:CFMS - ConforMIS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.5790 +0.04 (+7.42 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$0.5790
Today's Range$0.55 - $0.5845
52-Week Range$0.36 - $2.46
Volume454,018 shs
Average Volume582,073 shs
Market Capitalization$36.64 million
P/E Ratio-0.47
Dividend YieldN/A
Beta1.46
ConforMIS, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides ConforMIS Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, and Monaco. ConforMIS, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.

Receive CFMS News and Ratings via Email

Sign-up to receive the latest news and ratings for CFMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CFMS
CUSIPN/A
Phone781-345-9001

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$78.11 million
Book Value$1.02 per share

Profitability

Net Income$-53,580,000.00

Miscellaneous

Employees350
Market Cap$36.64 million
OptionableNot Optionable

ConforMIS (NASDAQ:CFMS) Frequently Asked Questions

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS Inc (NASDAQ:CFMS) posted its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.08. The medical instruments supplier earned $28.98 million during the quarter, compared to analysts' expectations of $19.21 million. ConforMIS had a negative net margin of 51.25% and a negative return on equity of 90.97%. View ConforMIS's Earnings History.

When is ConforMIS's next earnings date?

ConforMIS is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for ConforMIS.

What guidance has ConforMIS issued on next quarter's earnings?

ConforMIS updated its FY 2018 earnings guidance on Wednesday, October, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $77.5-78 million, compared to the consensus revenue estimate of $80.34 million.

What price target have analysts set for CFMS?

5 equities research analysts have issued 1-year price objectives for ConforMIS's shares. Their forecasts range from $2.50 to $3.00. On average, they expect ConforMIS's stock price to reach $2.8750 in the next year. This suggests a possible upside of 396.5% from the stock's current price. View Analyst Price Targets for ConforMIS.

What is the consensus analysts' recommendation for ConforMIS?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConforMIS in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ConforMIS.

What are Wall Street analysts saying about ConforMIS stock?

Here are some recent quotes from research analysts about ConforMIS stock:
  • 1. According to Zacks Investment Research, "ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company's iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States. " (11/5/2018)
  • 2. BTIG Research analysts commented, "Ongoing OUS Headwinds While CFMS 2Q18 results were a bit below our expectations (rev. of $19.1M (+3% Y/Y,+2% xFx) vs. BTIG/Consensus of $19.3M/$19.4M respectively, product rev. increased Y/Y for the first time since 1Q17, growing 5% to $18.0M. Mgmt. is making progress on US commercialization (albeit slower than investors will prefer). OUS continues to be challenged in Germany but mgmt. noted recent OUS sales leadership hires that may open up a few countries in 2H18. Mgmt. commentary on payor acceptance of CFMS products indicates increasing positive traction amongst some payers but CFMS is still not where it wants to be on rep growth, which missed the 20% growth target slightly. On the call, mgmt. announced plans to reduce OpEx while shuffling its product pipeline around." (8/2/2018)

Has ConforMIS been receiving favorable news coverage?

Media coverage about CFMS stock has been trending somewhat negative on Sunday, InfoTrie reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. ConforMIS earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:
  • Mr. Mark A. Augusti, CEO, Pres & Director (Age 52)
  • Mr. Paul S. Weiner CPA, CFO & Treasurer (Age 54)
  • Dr. Daniel Steines M.D., MS, Consultant (Age 49)
  • Mr. Ed Kilgallen, VP of Operations
  • Ms. Patricia A. Davis J.D., Chief Legal Officer, Gen. Counsel & Corp. Sec. (Age 52)

When did ConforMIS IPO?

(CFMS) raised $135 million in an IPO on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

How do I buy shares of ConforMIS?

Shares of CFMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of CFMS stock can currently be purchased for approximately $0.5790.

How big of a company is ConforMIS?

ConforMIS has a market capitalization of $36.64 million and generates $78.11 million in revenue each year. The medical instruments supplier earns $-53,580,000.00 in net income (profit) each year or ($1.24) on an earnings per share basis. ConforMIS employs 350 workers across the globe.

What is ConforMIS's official website?

The official website for ConforMIS is http://www.conformis.com.

How can I contact ConforMIS?

ConforMIS's mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The medical instruments supplier can be reached via phone at 781-345-9001 or via email at [email protected]


MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  261 (Vote Outperform)
Underperform Votes:  204 (Vote Underperform)
Total Votes:  465
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe CFMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel